Artelo Biosciences ARTL
NASDAQ ARTL
$4.07 -0.23 (-5.35%)
At close: Sep 29, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Notes Payables (2017 - 2025)

Updated

Artelo Biosciences (ARTL) recorded Notes Payables of $437,000 in Q4 2025, down 50.1% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Notes Payables (2017 - 2025) Analysis & Trends

Starting with Q2 2017, Artelo Biosciences' Notes Payables history includes 4 quarters.

  • The Q4 2025 figure is the lowest quarterly Notes Payables since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Artelo Biosciences 85,673.20 -5.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 437,000.00
Sep 30, 2025 875,000.00
May 31, 2017 29,720.00
Feb 28, 2017 29,569.00
API Access

Artelo Biosciences Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ARTL&period=max&api_key=YOUR_API_KEY